α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk

Ping Yang, William R. Bamlet, Zhifu D Sun, Jon Owen Ebbert, Marie Christine Aubry, William R. Taylor, Randolph Stuart Marks, Claude Deschamps, Stephen J. Swensen, Eric D Wieben, Julie M Cunningham, Lee Joseph Melton, Mariza De Andrade

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objective: Imbalance between α1-antitrypsin and neutrophil elastase is an underlying cause of lung tissue damage that may create a favorable host environment for carcinogenesis. We conducted a case-control study to investigate whether genetic variations indicative of α1- antitrypsin deficiency (A1ATD) or an excess of neutrophil elastase modify lung cancer risk Design: The case patients were 305 consecutively identified primary lung cancer patients, and the control subjects were 338 community residents. Protease inhibitor-1 (PI1), encoding α1-antitrypsin, was typed by an isoelectric focusing assay. Neutrophil elastase-2 (ELA2), encoding neutrophil elastase, was typed by two single-nucleotide polymorphism sites. Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, and family history of lung cancer Results: Sex and ethnicity were comparable between case patients and control subjects, but case patients were more likely to be smokers, and to have a history of COPD, environmental tobacco smoke exposure, and a positive family history of lung cancer. Haplotype analysis indicated an overall strong association between the two ELA2 markers and lung cancer risk. Our best-fitting model showed significant and independent effects of the PI1-deficient allele (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.4 to 3.0) and the ELA2 T-G haplotype (OR, 4.1; 95% CI, 1.9 to 8.9) on lung cancer risk, and an increased risk (OR, 2.6; 95% CI, 2.4 to 2.8) for individuals carrying both a PI1-deficient allele and a G-G haplotype Conclusions: Genotypes indicative of A1ATD and/or an excess of neutrophil elastase are significantly associated with lung cancer risk. Our findings may provide opportunities to better understand the mechanisms of lung cancer development and risk reduction.

Original languageEnglish (US)
Pages (from-to)445-452
Number of pages8
JournalChest
Volume128
Issue number1
DOIs
StatePublished - Jul 2005

Fingerprint

Leukocyte Elastase
Lung Neoplasms
Protease Inhibitors
Odds Ratio
Haplotypes
Confidence Intervals
Smoke
Chronic Obstructive Pulmonary Disease
Tobacco
Logistic Models
Alleles
Isoelectric Focusing
Risk Reduction Behavior
Single Nucleotide Polymorphism
Case-Control Studies
Carcinogenesis
Genotype
Lung
pancreatic elastase II

Keywords

  • α-antitrypsin deficiency
  • Chronic obstructive
  • Leukocyte elastase
  • Lung neoplasm
  • Pulmonary disease
  • Tobacco smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. / Yang, Ping; Bamlet, William R.; Sun, Zhifu D; Ebbert, Jon Owen; Aubry, Marie Christine; Taylor, William R.; Marks, Randolph Stuart; Deschamps, Claude; Swensen, Stephen J.; Wieben, Eric D; Cunningham, Julie M; Melton, Lee Joseph; De Andrade, Mariza.

In: Chest, Vol. 128, No. 1, 07.2005, p. 445-452.

Research output: Contribution to journalArticle

Yang, Ping ; Bamlet, William R. ; Sun, Zhifu D ; Ebbert, Jon Owen ; Aubry, Marie Christine ; Taylor, William R. ; Marks, Randolph Stuart ; Deschamps, Claude ; Swensen, Stephen J. ; Wieben, Eric D ; Cunningham, Julie M ; Melton, Lee Joseph ; De Andrade, Mariza. / α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. In: Chest. 2005 ; Vol. 128, No. 1. pp. 445-452.
@article{9df7029872d4492aa2530a0f06cea61f,
title = "α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk",
abstract = "Objective: Imbalance between α1-antitrypsin and neutrophil elastase is an underlying cause of lung tissue damage that may create a favorable host environment for carcinogenesis. We conducted a case-control study to investigate whether genetic variations indicative of α1- antitrypsin deficiency (A1ATD) or an excess of neutrophil elastase modify lung cancer risk Design: The case patients were 305 consecutively identified primary lung cancer patients, and the control subjects were 338 community residents. Protease inhibitor-1 (PI1), encoding α1-antitrypsin, was typed by an isoelectric focusing assay. Neutrophil elastase-2 (ELA2), encoding neutrophil elastase, was typed by two single-nucleotide polymorphism sites. Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, and family history of lung cancer Results: Sex and ethnicity were comparable between case patients and control subjects, but case patients were more likely to be smokers, and to have a history of COPD, environmental tobacco smoke exposure, and a positive family history of lung cancer. Haplotype analysis indicated an overall strong association between the two ELA2 markers and lung cancer risk. Our best-fitting model showed significant and independent effects of the PI1-deficient allele (odds ratio [OR], 2.0; 95{\%} confidence interval [CI], 1.4 to 3.0) and the ELA2 T-G haplotype (OR, 4.1; 95{\%} CI, 1.9 to 8.9) on lung cancer risk, and an increased risk (OR, 2.6; 95{\%} CI, 2.4 to 2.8) for individuals carrying both a PI1-deficient allele and a G-G haplotype Conclusions: Genotypes indicative of A1ATD and/or an excess of neutrophil elastase are significantly associated with lung cancer risk. Our findings may provide opportunities to better understand the mechanisms of lung cancer development and risk reduction.",
keywords = "α-antitrypsin deficiency, Chronic obstructive, Leukocyte elastase, Lung neoplasm, Pulmonary disease, Tobacco smoking",
author = "Ping Yang and Bamlet, {William R.} and Sun, {Zhifu D} and Ebbert, {Jon Owen} and Aubry, {Marie Christine} and Taylor, {William R.} and Marks, {Randolph Stuart} and Claude Deschamps and Swensen, {Stephen J.} and Wieben, {Eric D} and Cunningham, {Julie M} and Melton, {Lee Joseph} and {De Andrade}, Mariza",
year = "2005",
month = "7",
doi = "10.1378/chest.128.1.445",
language = "English (US)",
volume = "128",
pages = "445--452",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk

AU - Yang, Ping

AU - Bamlet, William R.

AU - Sun, Zhifu D

AU - Ebbert, Jon Owen

AU - Aubry, Marie Christine

AU - Taylor, William R.

AU - Marks, Randolph Stuart

AU - Deschamps, Claude

AU - Swensen, Stephen J.

AU - Wieben, Eric D

AU - Cunningham, Julie M

AU - Melton, Lee Joseph

AU - De Andrade, Mariza

PY - 2005/7

Y1 - 2005/7

N2 - Objective: Imbalance between α1-antitrypsin and neutrophil elastase is an underlying cause of lung tissue damage that may create a favorable host environment for carcinogenesis. We conducted a case-control study to investigate whether genetic variations indicative of α1- antitrypsin deficiency (A1ATD) or an excess of neutrophil elastase modify lung cancer risk Design: The case patients were 305 consecutively identified primary lung cancer patients, and the control subjects were 338 community residents. Protease inhibitor-1 (PI1), encoding α1-antitrypsin, was typed by an isoelectric focusing assay. Neutrophil elastase-2 (ELA2), encoding neutrophil elastase, was typed by two single-nucleotide polymorphism sites. Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, and family history of lung cancer Results: Sex and ethnicity were comparable between case patients and control subjects, but case patients were more likely to be smokers, and to have a history of COPD, environmental tobacco smoke exposure, and a positive family history of lung cancer. Haplotype analysis indicated an overall strong association between the two ELA2 markers and lung cancer risk. Our best-fitting model showed significant and independent effects of the PI1-deficient allele (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.4 to 3.0) and the ELA2 T-G haplotype (OR, 4.1; 95% CI, 1.9 to 8.9) on lung cancer risk, and an increased risk (OR, 2.6; 95% CI, 2.4 to 2.8) for individuals carrying both a PI1-deficient allele and a G-G haplotype Conclusions: Genotypes indicative of A1ATD and/or an excess of neutrophil elastase are significantly associated with lung cancer risk. Our findings may provide opportunities to better understand the mechanisms of lung cancer development and risk reduction.

AB - Objective: Imbalance between α1-antitrypsin and neutrophil elastase is an underlying cause of lung tissue damage that may create a favorable host environment for carcinogenesis. We conducted a case-control study to investigate whether genetic variations indicative of α1- antitrypsin deficiency (A1ATD) or an excess of neutrophil elastase modify lung cancer risk Design: The case patients were 305 consecutively identified primary lung cancer patients, and the control subjects were 338 community residents. Protease inhibitor-1 (PI1), encoding α1-antitrypsin, was typed by an isoelectric focusing assay. Neutrophil elastase-2 (ELA2), encoding neutrophil elastase, was typed by two single-nucleotide polymorphism sites. Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, and family history of lung cancer Results: Sex and ethnicity were comparable between case patients and control subjects, but case patients were more likely to be smokers, and to have a history of COPD, environmental tobacco smoke exposure, and a positive family history of lung cancer. Haplotype analysis indicated an overall strong association between the two ELA2 markers and lung cancer risk. Our best-fitting model showed significant and independent effects of the PI1-deficient allele (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.4 to 3.0) and the ELA2 T-G haplotype (OR, 4.1; 95% CI, 1.9 to 8.9) on lung cancer risk, and an increased risk (OR, 2.6; 95% CI, 2.4 to 2.8) for individuals carrying both a PI1-deficient allele and a G-G haplotype Conclusions: Genotypes indicative of A1ATD and/or an excess of neutrophil elastase are significantly associated with lung cancer risk. Our findings may provide opportunities to better understand the mechanisms of lung cancer development and risk reduction.

KW - α-antitrypsin deficiency

KW - Chronic obstructive

KW - Leukocyte elastase

KW - Lung neoplasm

KW - Pulmonary disease

KW - Tobacco smoking

UR - http://www.scopus.com/inward/record.url?scp=22244461873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244461873&partnerID=8YFLogxK

U2 - 10.1378/chest.128.1.445

DO - 10.1378/chest.128.1.445

M3 - Article

C2 - 16002971

AN - SCOPUS:22244461873

VL - 128

SP - 445

EP - 452

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -